Sequoia, GIC Invest in TPG's Novotech at $2.3 Billion Valuation

Sequoia, GIC Invest in TPG’s Novotech at $2.3 Billion Valuation
Bloomberg
2/1/2021
© Bloomberg
Laboratory Research On Covid-19
(Bloomberg) -- Sequoia Capital and Singapore sovereign fund GIC Pte are among investors that agreed to buy a stake in clinical research and testing provider Novotech Pty from TPG, people with knowledge of the matter said.
Kaiser Foundation Hospitals also plans to invest in Novotech, according to the people, who asked not to be identified because the information is private. TPG is selling more than 10% of Novotech in a transaction valuing the company at over $2.3 billion, said Joel Thickins, head of Australia and New Zealand for TPG Capital Asia.

Related Keywords

Australia , Taiwan , New Zealand , Hong Kong , Sydney , New South Wales , Singapore , China , South Korea , Novotech Pty , Anand Tharmaratnam , Joel Thickins , Laboratory Research On Covid , Bloomberg Laboratory Research On Covid , Kaiser Foundation Hospitals , Foundation Hospitals , Southeast Asia , ஆஸ்திரேலியா , டைவாந் , புதியது ஜீலாந்து , ஹாங் காங் , சிட்னி , புதியது தெற்கு வேல்ஸ் , சிங்கப்பூர் , சீனா , தெற்கு கொரியா , கைசர் அடித்தளம் மருத்துவமனைகள் , அடித்தளம் மருத்துவமனைகள் , தென்கிழக்கு ஆசியா ,